Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 18, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

3.5K

Pancreatic Myeloid Sarcoma.

Ammar Al-Obaidi1, Nathaniel A Parker1, Yasmine Hussein Agha1

  • 1Internal Medicine, University of Kansas School of Medicine, Wichita, USA.

Cureus
|June 13, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal Cryptococcosis in immunosuppressed patients.

Infectious diseases now·2026
Same author

Complementary Medicine in Oncology: A Dual-Perspective Examination of Patient Use and Clinician Attitudes.

Kansas journal of medicine·2026
Same author

When Inflammation Mimics Malignancy: Recognizing VEXAS Syndrome in Oncology Practice.

Kansas journal of medicine·2026
Same author

Vitamins and Cancer Risk: A Comprehensive Review of Epidemiologic and Clinical Evidence.

Kansas journal of medicine·2026
Same author

Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

Small cell lung cancer progressing into fatal ascending motor and sensory polyneuropathy despite dramatic response to chemotherapy: A case report: Retraction.

Medicine·2025

Myeloid sarcoma, a rare tumor of immature myeloid cells, presents unique diagnostic and prognostic challenges. Early detection and accurate diagnosis are crucial for improving patient survival rates.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Myeloid sarcoma is an extramedullary tumor composed of immature myeloid cells.
  • It can occur independently or alongside other hematologic malignancies.

Observation:

  • Outcomes for myeloid sarcoma are highly variable.
  • Clinical presentation varies significantly based on tumor location, size, and tissue infiltration.
  • Diagnosis requires a high index of suspicion, tissue sampling, auxiliary studies, and bone marrow evaluation.

Findings:

  • Current treatment for myeloid sarcoma mirrors that of acute myeloid leukemia.
  • Delayed or missed diagnosis is linked to poor survival rates.
  • Prognostic factors for myeloid sarcoma are not well-understood.
Keywords:
acute myeloid leukemiaallogenic bone marrow transplantchemotherapyextramedullary leukemiagranulocytic sarcomamyeloid sarcomapancreatic sarcoma

More Related Videos

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.5K
A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

30.0K

Related Experiment Videos

Last Updated: Dec 18, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

3.5K
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.5K
A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

30.0K

Implications:

  • Improved diagnostic strategies are essential for myeloid sarcoma.
  • Further research is needed to elucidate prognostic factors.
  • Understanding myeloid sarcoma is critical for improving patient outcomes in hematologic oncology.